Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionApriem Advisors
Latest Disclosed Ownership2,500 shares
Latest Disclosed Value $ 879,625
Apriem Advisors ownership in AMGN / Amgen Inc.

On May 14, 2026 - Apriem Advisors filed a 13F-HR form disclosing ownership of 2,500 shares of Amgen Inc. (CH:AMGN) valued at $879,625 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,500 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 2,500 0 0.00 880 7.46 0.0839
2026-02-13 2025-12-31 13F AMGEN COM 031162100 2,500 5 0.20 818 16.19 0.0751
2025-11-10 2025-09-30 13F AMGEN COM 031162100 2,495 5 0.20 704 1.29 0.0666
2025-08-14 2025-06-30 13F AMGEN COM 031162100 2,490 0 0.00 695 -10.32 0.0739
2025-05-15 2025-03-31 13F AMGEN COM 031162100 2,490 -126 -4.82 776 13.80 0.0909
2025-02-05 2024-12-31 13F AMGEN COM 031162100 2,616 92 3.65 682 -16.24 0.0781
2024-11-14 2024-09-30 13F AMGEN COM 031162100 2,524 0 0.00 813 3.17 0.0950
2024-08-14 2024-06-30 13F AMGEN COM 031162100 2,524 44 1.77 789 11.77 0.0965
2024-05-15 2024-03-31 13F AMGEN COM 031162100 2,480 25 1.02 705 -0.28 0.0886
2024-02-14 2023-12-31 13F AMGEN COM 031162100 2,455 0 0.00 707 7.28 0.0945
2023-11-13 2023-09-30 13F AMGEN COM 031162100 2,455 0 0.00 660 20.92 0.0967
2023-08-08 2023-06-30 13F AMGEN COM 031162100 2,455 0 0.00 545 -8.09 0.0817
2023-05-12 2023-03-31 13F AMGEN COM 031162100 2,455 -60 -2.39 593 -10.15 0.0950
2023-02-13 2022-12-31 13F AMGEN COM 031162100 2,515 -170 -6.33 661 9.09 0.1145
2022-11-14 2022-09-30 13F AMGEN COM 031162100 2,685 0 0.00 605 -7.35 0.1091
2022-08-08 2022-06-30 13F AMGEN COM 031162100 2,685 0 0.00 653 0.62 0.1125
2022-05-10 2022-03-31 13F AMGEN COM 031162100 2,685 -100 -3.59 649 3.51 0.0952
2022-02-09 2021-12-31 13F AMGEN COM 031162100 2,785 95 3.53 627 9.62 0.0887
2021-11-12 2021-09-30 13F AMGEN COM 031162100 2,690 80 3.07 572 -10.06 0.0820
2021-08-10 2021-06-30 13F AMGEN COM 031162100 2,610 74 2.92 636 0.79 0.0949
2021-05-10 2021-03-31 13F AMGEN COM 031162100 2,536 13 0.52 631 8.79 0.0978
2021-02-04 2020-12-31 13F AMGEN COM 031162100 2,523 26 1.04 580 -8.66 0.1034
2020-11-10 2020-09-30 13F AMGEN COM 031162100 2,497 -168 -6.30 635 0.95 0.1166
2020-08-07 2020-06-30 13F AMGEN COM 031162100 2,665 90 3.50 629 20.50 0.1292
2020-05-07 2020-03-31 13F AMGEN COM 031162100 2,575 23 0.90 522 -15.12 0.1265
2020-02-10 2019-12-31 13F AMGEN COM 031162100 2,552 0 0.00 615 24.49 0.1179
2019-11-12 2019-09-30 13F AMGEN COM 031162100 2,552 193 8.18 494 13.56 0.1095
2019-08-14 2019-06-30 13F AMGEN COM 031162100 2,359 -160 -6.35 435 -9.19 0.1363
2019-05-15 2019-03-31 13F AMGEN COM 031162100 2,519 35 1.41 479 -1.03 0.1268
2019-02-19 2018-12-31 13F AMGEN COM 031162100 2,484 380 18.06 484 11.01 0.1702
2018-11-14 2018-09-30 13F AMGEN cs 031162100 2,104 0 0.00 436 12.37 0.0954
2018-08-14 2018-06-30 13F AMGEN cs 031162100 2,104 700 49.86 388 62.34 0.0872
2018-05-11 2018-03-31 13F AMGEN cs 031162100 1,404 1,404 239 0.0583
2018-02-14 2017-12-31 13F AMGEN cs 031162100 0 -1,119 -100.00 0 -100.00
2017-11-14 2017-09-30 13F AMGEN cs 031162100 1,119 -82 -6.83 209 0.97 0.0520
2017-08-04 2017-06-30 13F AMGEN cs 031162100 1,201 2 0.17 207 5.08 0.0548
2017-05-13 2017-03-31 13F AMGEN cs 031162100 1,199 517 75.81 197 97.00 0.0535
2017-02-14 2016-12-31 13F AMGEN cs 031162100 682 -98 -12.56 100 -23.08 0.0297
2016-11-14 2016-09-30 13F AMGEN cs 031162100 780 0 0.00 130 9.24 0.0387
2016-08-12 2016-06-30 13F AMGEN cs 031162100 780 -22 -2.74 119 -0.83 0.0387
2016-05-13 2016-03-31 13F AMGEN cs 031162100 802 -378 -32.03 120 -37.50 0.0472
2016-02-09 2015-12-31 13F AMGEN cs 031162100 1,180 0 0.00 192 17.79 0.0684
2015-11-13 2015-09-30 13F AMGEN cs 031162100 1,180 180 18.00 163 5.84 0.0603
2015-08-14 2015-06-30 13F AMGEN cs 031162100 1,000 -168 -14.38 154 -17.65 0.0529
2015-05-07 2015-03-31 13F AMGEN cs 031162100 1,168 568 94.67 187 94.79 0.0648
2015-02-12 2014-12-31 13F AMGEN cs 031162100 600 0 0.00 96 14.29 0.0354
2014-11-10 2014-09-30 13F AMGEN cs 031162100 600 -5,572 -90.28 84 -88.51 0.0321
2014-08-11 2014-06-30 13F AMGEN cs 031162100 6,172 0 0.00 731 -3.94 0.2791
2014-05-13 2014-03-31 13F AMGEN cs 031162100 6,172 0 0.00 761 8.10 0.2879
2014-02-14 2013-12-31 13F AMGEN cs 031162100 6,172 0 0.00 704 1.88 0.2758
2013-11-06 2013-09-30 13F AMGEN cs 031162100 6,172 0 0.00 691 13.46 0.2999
2013-08-15 2013-06-30 13F AMGEN cs 031162100 6,172 6,172 609 0.2984
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.